Literature DB >> 17360760

Sodium butyrate: a chemical inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse model.

Donna M Neumann1, Partha S Bhattacharjee, James M Hill.   

Abstract

Recent studies have explored the chromatin structures associated with the herpes simplex virus type 1 (HSV-1) genome during latency, particularly with regard to specific histone tail modifications such as acetylation and dimethylation. The objective of our present study was to develop a rapid systemic method of in vivo HSV-1 reactivation to further explore the changes that occur in the chromatin structures associated with HSV-1 at early time points after the initiation of HSV reactivation. We present a uniform, rapid, and reliable method of in vivo HSV-1 reactivation in mice that yields high reactivation frequencies (75 to 100%) by using sodium butyrate, a histone deacetylase inhibitor, and demonstrate that the reactivating virus can be detected at the original site of infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360760      PMCID: PMC1900314          DOI: 10.1128/JVI.00070-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  A cAMP response element within the latency-associated transcript promoter of HSV-1 facilitates induced ocular reactivation in a mouse hyperthermia model.

Authors:  M E Marquart; X Zheng; R K Tran; H W Thompson; D C Bloom; J M Hill
Journal:  Virology       Date:  2001-05-25       Impact factor: 3.616

2.  Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation.

Authors:  N M Sawtell
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription.

Authors:  Nicole J Kubat; Antonio L Amelio; Nicole V Giordani; David C Bloom
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits.

Authors:  G C Perng; S M Slanina; A Yukht; H Ghiasi; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion.

Authors:  Shiro Higaki; Bryan M Gebhardt; Walter J Lukiw; Hilary W Thompson; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

7.  The effect of immunosuppression on viral encephalitis, with special reference to cyclophosphamide.

Authors:  I Zlotnik; C E Smith; D P Grant; S Peacock
Journal:  Br J Exp Pathol       Date:  1970-08

8.  Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice.

Authors:  Robert J Ferrante; James K Kubilus; Junghee Lee; Hoon Ryu; Ayshe Beesen; Birgit Zucker; Karen Smith; Neil W Kowall; Rajiv R Ratan; Ruth Luthi-Carter; Steven M Hersch
Journal:  J Neurosci       Date:  2003-10-15       Impact factor: 6.167

9.  Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression.

Authors:  Nicole J Kubat; Robert K Tran; Peterjon McAnany; David C Bloom
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  A chromatin insulator-like element in the herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities.

Authors:  Antonio L Amelio; Peterjon K McAnany; David C Bloom
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

View more
  21 in total

1.  Recruitment of the transcriptional coactivator HCF-1 to viral immediate-early promoters during initiation of reactivation from latency of herpes simplex virus type 1.

Authors:  Zackary Whitlow; Thomas M Kristie
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

Review 2.  The checkpoints of viral gene expression in productive and latent infection: the role of the HDAC/CoREST/LSD1/REST repressor complex.

Authors:  Bernard Roizman
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

3.  HSV carrying WT REST establishes latency but reactivates only if the synthesis of REST is suppressed.

Authors:  Guoying Zhou; Te Du; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

4.  CTCF Binding Sites in the Herpes Simplex Virus 1 Genome Display Site-Specific CTCF Occupation, Protein Recruitment, and Insulator Function.

Authors:  Shannan D Washington; Farhana Musarrat; Monica K Ertel; Gregory L Backes; Donna M Neumann
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

5.  CTCF occupation of the herpes simplex virus 1 genome is disrupted at early times postreactivation in a transcription-dependent manner.

Authors:  Monica K Ertel; Amy L Cammarata; Rebecca J Hron; Donna M Neumann
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

6.  Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus.

Authors:  Christian Clement; Partha S Bhattacharjee; Manish Kumar; Timothy P Foster; Hilary W Thompson; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-28       Impact factor: 4.799

7.  Induction of cellular stress overcomes the requirement of herpes simplex virus type 1 for immediate-early protein ICP0 and reactivates expression from quiescent viral genomes.

Authors:  Chris M Preston; Mary Jane Nicholl
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

8.  In vivo changes in the patterns of chromatin structure associated with the latent herpes simplex virus type 1 genome in mouse trigeminal ganglia can be detected at early times after butyrate treatment.

Authors:  Donna M Neumann; Partha S Bhattacharjee; Nicole V Giordani; David C Bloom; James M Hill
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

9.  Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters.

Authors:  Srividya Ramachandran; Jared E Knickelbein; Christina Ferko; Robert L Hendricks; Paul R Kinchington
Journal:  Virology       Date:  2008-07-11       Impact factor: 3.616

Review 10.  Strength in diversity: Understanding the pathways to herpes simplex virus reactivation.

Authors:  Jon B Suzich; Anna R Cliffe
Journal:  Virology       Date:  2018-07-14       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.